MedTrace Logo

Hyoscine Butyl Bromide for Management of Prolonged Labor

NCT01854073 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2017-03-10

No results posted yet for this study

Summary

To determine the value of using Hyoscine as an antispasmodic drug for the management of prolonged labor in nulliparous women at term.

Conditions

  • Prolonged Labor

Interventions

DRUG

Hyoscine butyl bromide

DRUG

Normal saline

Sponsors & Collaborators

  • Armed Forces Hospitals, Southern Region, Saudi Arabia

    collaborator OTHER_GOV

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Mohamed Ellaithy, MD · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2017-04-30
Completion
2017-06-30

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01854073 on ClinicalTrials.gov